Michael Brownlee
Michael Brownlee publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Clinical Biochemistry, on topics such as Advanced Glycation End Products research, Diabetes Management and Research and Diabetes and associated disorders.
- World rank
- #36,663 of 7,710,434 ranked researchers
- Rank in United States
- #14,024 of 1,627,098
- Works
- 141
- Citations
- 46k
- Citations per work
- 328.5
What does Michael Brownlee research?
Michael Brownlee's work is mostly in Biochemistry, Genetics and Molecular Biology (31%), Medicine (29%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5639.9%
- Life Sciences4431.1%
- Health Sciences4129.0%
- Medicine4129.0%
- 1Endocrinology, Diabetes and Metabolism18% of their works
- 2Molecular Biology14% of their works
- 3Clinical Biochemistry11% of their works
- 4Physiology7% of their works
- 5Genetics6% of their works
- 6Surgery4% of their works
Research topics
- Advanced Glycation End Products research
- Diabetes Management and Research
- Diabetes and associated disorders
- Adipose Tissue and Metabolism
- Glycosylation and Glycoproteins Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pancreatic function and diabetes
Which keywords describe Michael Brownlee's research?
The keywords of their largest research topics: Diabetes, Oxidative Stress, Glycemic Control, Insulin Therapy, Advanced Glycation End Products, HMGB1, Type 1 Diabetes and Continuous Glucose Monitoring.
- ß-Cell Dysfunction
- Type 2 Diabetes
- Glycosylation
- Critical Care
- Thermogenesis
- Brown Adipose Tissue
- Hypoglycemia
- Continuous Glucose Monitoring
- HMGB1
- Insulin Therapy
- Oxidative Stress
- Diabetes
- Glycemic Control
- Advanced Glycation End Products
- Type 1 Diabetes
- Diabetes Mellitus
- Autoimmunity
- Genetics
- Cardiovascular Outcomes
- Glycans
- Hyperglycemia
- Pancreatic Islets
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Diabetes642 topics
- Oxidative Stress522 topics
- Glycemic Control473 topics
- Insulin Therapy473 topics
- Advanced Glycation End Products411 topic
- HMGB1411 topic
- Type 1 Diabetes392 topics
- Continuous Glucose Monitoring231 topic
- Diabetes Mellitus232 topics
- Hypoglycemia231 topic
- Autoimmunity161 topic
- Brown Adipose Tissue161 topic
- Genetics161 topic
- Thermogenesis161 topic
- Cardiovascular Outcomes121 topic
- Critical Care121 topic
- Glycans121 topic
- Glycosylation121 topic
- Hyperglycemia121 topic
- Type 2 Diabetes121 topic
- Pancreatic Islets111 topic
- ß-Cell Dysfunction111 topic
Where does Michael Brownlee work?
Michael Brownlee's main affiliation in the publication record is Albert Einstein College of Medicine, United States.
How many publications and citations does Michael Brownlee have?
OpenAlex counts 141 works and 46,315 citations for Michael Brownlee, an h-index of 66, ranking #36,663 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Michael Brownlee
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Brownlee. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.